Active substances

Niraparib›

L01XK02 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Poly (ADP-ribose) polymerase (PARP) inhibitors

Indicated for: cancer

Niraparib + abiraterone›

L01XK52 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Poly (ADP-ribose) polymerase (PARP) inhibitors

Indicated for: prostate cancer

Nirmatrelvir + ritonavir›

J05AE30 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Indicated for: COVID-19

Nirogacestat›

L01XX81 Antineoplastic and immunomodulating agents | Other antineoplastic agents

Indicated for: desmoid tumors

Nirsevimab›

J06BD08 Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies

Indicated for: prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV)

Nisoldipine›

C08CA07 Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives

Indicated for: hypertension

Nitisinone›

A16AX04 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products

Indicated for: hereditary tyrosinemia type 1

Nitrazepam›

N05CD02 Nervous system | Hypnotics and sedatives | Benzodiazepine derivatives

Indicated for: insomnia

Nitrendipine›

C08CA08 Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives

Indicated for: hypertension

Nitrendipine + enalapril›

C09BB02 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers

Indicated for: hypertension

Nitric oxide›

R07AX01 Respiratory system | Other respiratory system products | Other respiratory system products

Indicated for: pulmonary hypertension; pulmonary function testing

Nitrofurantoin›

J01XE01 Antiinfectives for systemic use | Other antibacterials | Nitrofuran derivatives

Indicated for: bacterial urinary tract infections

Nitroglycerine›

C01DA02 Cardiovascular system | Vasodilators used in cardiac diseases | Organic nitrates

Indicated for: angina pectoris

Nitrous oxide›

N01AX13 Nervous system | Anesthetics | Anesthetics, general | Other general anesthetics

Indicated for: general anesthesia; procedural sedation

Nitrous oxide + oxygen›

N01AX63 Nervous system | Anesthetics | Anesthetics, general | Other general anesthetics

Indicated for: general anesthesia; procedural sedation

Nitroxoline›

J01XX07 Antiinfectives for systemic use | Other antibacterials

Indicated for: bacterial infections

Nivolumab›

L01FF01 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Indicated for: cancer

Nivolumab + relatlimab›

L01FY02 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Combinations of monoclonal antibodies and antibody drug conjugates

Indicated for: cancer

Nizatidine›

A02BA04 Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | H2-receptor antagonists

Indicated for: peptic ulcer; gastroesophageal reflux

Nomegestrol›

G03DB04 Genito urinary system and sex hormones | Progestogens | Pregnadien derivatives

Indicated for: contraception; gynecologic hormonal disorders

Nomegestrol + estradiol›

G03AA14 Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations

Indicated for: menopausal symptoms

Nonacog alfa›

B02BD04 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors

Indicated for: bleeding; coagulation disorders

Nonacog beta pegol›

B02BD04 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors

Indicated for: hemophilia B

Nonivamide + nicoboxil›

M02ABN1 Musculo-skeletal system | Topical products for joint and muscular pain | Topical products for joint and muscular pain | Capsaicin and similar agents

Indicated for: local muscle and joint pain

Noradrenaline›

C01CA03 Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents

Indicated for: shock; acute hypotension

Norelgestromine + ethinylestradiol›

G03AA13 Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations

Indicated for: contraception

Norfloxacin›

J01MA06 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones

Indicated for: bacterial infections

Norgestimate + ethinylestradiol›

G03AA11 Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations

Indicated for: contraception

Normal human immunoglobulin›

J06BA01 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Indicated for: immunosuppression

Normal human immunoglobulin for extravascular administration›

J06BA01 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Indicated for: immunosuppression